↓ Skip to main content

Intercalated Treatment Following Rebiopsy Is Associated with a Shorter Progression-Free Survival of Osimertinib Treatment

Overview of attention for article published in Cancer Research and Treatment : Official Journal of Korean Cancer Association, December 2017
Altmetric Badge

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Intercalated Treatment Following Rebiopsy Is Associated with a Shorter Progression-Free Survival of Osimertinib Treatment
Published in
Cancer Research and Treatment : Official Journal of Korean Cancer Association, December 2017
DOI 10.4143/crt.2017.460
Pubmed ID
Authors

Jeng-Sen Tseng, Tsung-Ying Yang, Kun-Chieh Chen, Kuo-Hsuan Hsu, Yen-Hsiang Huang, Kang-Yi Su, Sung-Liang Yu, Gee-Chen Chang

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Lecturer 1 17%
Student > Master 1 17%
Unknown 4 67%
Readers by discipline Count As %
Nursing and Health Professions 2 33%
Unknown 4 67%